Cargando…
Evaluation of circulating leucocyte populations both in subjects with previous SARS-COV-2 infection and in healthy subjects after vaccination
Innate immune mechanisms are central players in response to the binding of pathogens to pattern-recognition receptors providing a crucial initial block on viral replication. Moreover, innate immune response mobilizes cells of the cellular-mediated immune system, which develop into effector cells tha...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802555/ https://www.ncbi.nlm.nih.gov/pubmed/35114198 http://dx.doi.org/10.1016/j.jim.2022.113230 |
_version_ | 1784642706044092416 |
---|---|
author | Grimaldi, Vincenzo Benincasa, Giuditta Moccia, Giusi Sansone, Annunziata Signoriello, Giuseppe Napoli, Claudio |
author_facet | Grimaldi, Vincenzo Benincasa, Giuditta Moccia, Giusi Sansone, Annunziata Signoriello, Giuseppe Napoli, Claudio |
author_sort | Grimaldi, Vincenzo |
collection | PubMed |
description | Innate immune mechanisms are central players in response to the binding of pathogens to pattern-recognition receptors providing a crucial initial block on viral replication. Moreover, innate immune response mobilizes cells of the cellular-mediated immune system, which develop into effector cells that promote viral clearance. Here, we observed circulating leukocyte T cell response in healthy subjects, COVID-19 infected, and in healthy vaccinated subjects. We found a significant CD8(+) T cells (p < 0,05) decrease and an augmented CD4(+)/CD8(+) ratio (p < 0,05) in COVID-19 infected group compared with vaccinated subjects. In addition, healthy vaccinated subjects have a significant increased expression of CD8(+) T cells, and a reduction of CD4(+)/CD8(+) ratio with respect to subjects previously COVID-19 infected. Central Memory and Terminal Effector Memory cells (TEMRA) increased after vaccine but not among groups. |
format | Online Article Text |
id | pubmed-8802555 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88025552022-01-31 Evaluation of circulating leucocyte populations both in subjects with previous SARS-COV-2 infection and in healthy subjects after vaccination Grimaldi, Vincenzo Benincasa, Giuditta Moccia, Giusi Sansone, Annunziata Signoriello, Giuseppe Napoli, Claudio J Immunol Methods Technical Note Innate immune mechanisms are central players in response to the binding of pathogens to pattern-recognition receptors providing a crucial initial block on viral replication. Moreover, innate immune response mobilizes cells of the cellular-mediated immune system, which develop into effector cells that promote viral clearance. Here, we observed circulating leukocyte T cell response in healthy subjects, COVID-19 infected, and in healthy vaccinated subjects. We found a significant CD8(+) T cells (p < 0,05) decrease and an augmented CD4(+)/CD8(+) ratio (p < 0,05) in COVID-19 infected group compared with vaccinated subjects. In addition, healthy vaccinated subjects have a significant increased expression of CD8(+) T cells, and a reduction of CD4(+)/CD8(+) ratio with respect to subjects previously COVID-19 infected. Central Memory and Terminal Effector Memory cells (TEMRA) increased after vaccine but not among groups. Elsevier B.V. 2022-03 2022-01-31 /pmc/articles/PMC8802555/ /pubmed/35114198 http://dx.doi.org/10.1016/j.jim.2022.113230 Text en © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Technical Note Grimaldi, Vincenzo Benincasa, Giuditta Moccia, Giusi Sansone, Annunziata Signoriello, Giuseppe Napoli, Claudio Evaluation of circulating leucocyte populations both in subjects with previous SARS-COV-2 infection and in healthy subjects after vaccination |
title | Evaluation of circulating leucocyte populations both in subjects with previous SARS-COV-2 infection and in healthy subjects after vaccination |
title_full | Evaluation of circulating leucocyte populations both in subjects with previous SARS-COV-2 infection and in healthy subjects after vaccination |
title_fullStr | Evaluation of circulating leucocyte populations both in subjects with previous SARS-COV-2 infection and in healthy subjects after vaccination |
title_full_unstemmed | Evaluation of circulating leucocyte populations both in subjects with previous SARS-COV-2 infection and in healthy subjects after vaccination |
title_short | Evaluation of circulating leucocyte populations both in subjects with previous SARS-COV-2 infection and in healthy subjects after vaccination |
title_sort | evaluation of circulating leucocyte populations both in subjects with previous sars-cov-2 infection and in healthy subjects after vaccination |
topic | Technical Note |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802555/ https://www.ncbi.nlm.nih.gov/pubmed/35114198 http://dx.doi.org/10.1016/j.jim.2022.113230 |
work_keys_str_mv | AT grimaldivincenzo evaluationofcirculatingleucocytepopulationsbothinsubjectswithprevioussarscov2infectionandinhealthysubjectsaftervaccination AT benincasagiuditta evaluationofcirculatingleucocytepopulationsbothinsubjectswithprevioussarscov2infectionandinhealthysubjectsaftervaccination AT mocciagiusi evaluationofcirculatingleucocytepopulationsbothinsubjectswithprevioussarscov2infectionandinhealthysubjectsaftervaccination AT sansoneannunziata evaluationofcirculatingleucocytepopulationsbothinsubjectswithprevioussarscov2infectionandinhealthysubjectsaftervaccination AT signoriellogiuseppe evaluationofcirculatingleucocytepopulationsbothinsubjectswithprevioussarscov2infectionandinhealthysubjectsaftervaccination AT napoliclaudio evaluationofcirculatingleucocytepopulationsbothinsubjectswithprevioussarscov2infectionandinhealthysubjectsaftervaccination |